These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37385947)

  • 1. Consensus recommendations for the screening, diagnosis, and management of
    Leung WK; Cheung KS; Sham PCO; Tang RSY; Loo CK; Hsu ASJ; Cheung TK; Lam LY; Chiu BCF; Wu JCY
    Hong Kong Med J; 2023 Dec; 29(6):532-541. PubMed ID: 37385947
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.
    Sheu BS; Wu MS; Chiu CT; Lo JC; Wu DC; Liou JM; Wu CY; Cheng HC; Lee YC; Hsu PI; Chang CC; Chang WL; Lin JT
    Helicobacter; 2017 Jun; 22(3):. PubMed ID: 28066960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
    Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC
    Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
    Leung WK; Wong IOL; Cheung KS; Yeung KF; Chan EW; Wong AYS; Chen L; Wong ICK; Graham DY
    Gastroenterology; 2018 Jul; 155(1):67-75. PubMed ID: 29550592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
    Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
    Lin LC; Hsu TH; Huang KW; Tam KW
    World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
    Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK
    Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.
    Fock KM; Katelaris P; Sugano K; Ang TL; Hunt R; Talley NJ; Lam SK; Xiao SD; Tan HJ; Wu CY; Jung HC; Hoang BH; Kachintorn U; Goh KL; Chiba T; Rani AA;
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1587-600. PubMed ID: 19788600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fourth Mexican consensus on Helicobacter pylori.
    Bosques-Padilla FJ; Remes-Troche JM; González-Huezo MS; Pérez-Pérez G; Torres-López J; Abdo-Francis JM; Bielsa-Fernandez MV; Camargo MC; Esquivel-Ayanegui F; Garza-González E; Hernández-Guerrero AI; Herrera-Goepfert R; Huerta-Iga FM; Leal-Herrera Y; Lopéz-Colombo A; Ortiz-Olvera NX; Riquelme-Pérez A; Sampieri CL; Uscanga-Domínguez LF; Velarde-Ruiz Velasco JA
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(3):325-341. PubMed ID: 29941237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation.
    Bourke B; Ceponis P; Chiba N; Czinn S; Ferraro R; Fischbach L; Gold B; Hyunh H; Jacobson K; Jones NL; Koletzko S; Lebel S; Moayyedi P; Ridell R; Sherman P; van Zanten S; Beck I; Best L; Boland M; Bursey F; Chaun H; Cooper G; Craig B; Creuzenet C; Critch J; Govender K; Hassall E; Kaplan A; Keelan M; Noad G; Robertson M; Smith L; Stein M; Taylor D; Walters T; Persaud R; Whitaker S; Woodland R;
    Can J Gastroenterol; 2005 Jul; 19(7):399-408. PubMed ID: 16010300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Smith S; Boyle B; Brennan D; Buckley M; Crotty P; Doyle M; Farrell R; Hussey M; Kevans D; Malfertheiner P; Megraud F; Nugent S; O'Connor A; O'Morain C; Weston S; McNamara D
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):552-559. PubMed ID: 28350745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol.
    Han S; Deng Z; Cheung K; Lyu T; Chan P; Li Y; Ni L; Luo X; Li K
    BMC Gastroenterol; 2023 Jul; 23(1):231. PubMed ID: 37420205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.
    Singh SP; Ahuja V; Ghoshal UC; Makharia G; Dutta U; Zargar SA; Venkataraman J; Dutta AK; Mukhopadhyay AK; Singh A; Thapa BR; Vaiphei K; Sathiyasekaran M; Sahu MK; Rout N; Abraham P; Dalai PC; Rathi P; Sinha SK; Bhatia S; Patra S; Ghoshal U; Poddar U; Mouli VP; Kate V
    Indian J Gastroenterol; 2021 Aug; 40(4):420-444. PubMed ID: 34219211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in the prevalence of Helicobacter Pylori in symptomatic children: A 12-year retrospective study in a tertiary centre.
    Tang MYL; Chung PHY; Chan HY; Tam PKH; Wong KK
    J Pediatr Surg; 2019 Feb; 54(2):255-257. PubMed ID: 30497821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016).
    Jones NL; Koletzko S; Goodman K; Bontems P; Cadranel S; Casswall T; Czinn S; Gold BD; Guarner J; Elitsur Y; Homan M; Kalach N; Kori M; Madrazo A; Megraud F; Papadopoulou A; Rowland M;
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):991-1003. PubMed ID: 28541262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V Spanish Consensus Conference on Helicobacter pylori infection treatment.
    Gisbert JP; Alcedo J; Amador J; Bujanda L; Calvet X; Castro-Fernández M; Fernández-Salazar L; Gené E; Lanas Á; Lucendo AJ; Molina-Infante J; Nyssen OP; Pérez-Aisa A; Puig I
    Gastroenterol Hepatol; 2022 May; 45(5):392-417. PubMed ID: 34629204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.
    Lee VW; Chau TS; Chan AK; Lee KK; Waye MM; Ling TK; Chan FK
    J Clin Pharm Ther; 2010 Jun; 35(3):343-50. PubMed ID: 20831535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.